Your browser doesn't support javascript.
loading
Microbeam Irradiation of the Beating Rodent Heart: An Ex Vivo Study of Acute and Subacute Effects on Cardiac Function.
Lange, Falko; Kirschstein, Timo; Davis, Jeremy; Paino, Jason; Barnes, Micah; Klein, Mitzi; Porath, Katrin; Stöhlmacher, Paula; Fiedler, Stefan; Frank, Marcus; Köhling, Rüdiger; Hildebrandt, Guido; Hausermann, Daniel; Lerch, Michael; Schültke, Elisabeth.
Afiliação
  • Lange F; Oscar Langendorff Institute of Physiology, Rostock University Medical Centre, Rostock, Germany; Centre for Transdisciplinary Neurosciences Rostock, University of Rostock, Rostock, Germany.
  • Kirschstein T; Oscar Langendorff Institute of Physiology, Rostock University Medical Centre, Rostock, Germany; Centre for Transdisciplinary Neurosciences Rostock, University of Rostock, Rostock, Germany. Electronic address: timo.kirschstein@uni-rostock.de.
  • Davis J; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia; Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia.
  • Paino J; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia; Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia.
  • Barnes M; Australian Synchrotron-Australian Nuclear Science and Technology Organisation (ANSTO), Kulin Nation, Melbourne, Australia.
  • Klein M; Australian Synchrotron-Australian Nuclear Science and Technology Organisation (ANSTO), Kulin Nation, Melbourne, Australia.
  • Porath K; Oscar Langendorff Institute of Physiology, Rostock University Medical Centre, Rostock, Germany.
  • Stöhlmacher P; Oscar Langendorff Institute of Physiology, Rostock University Medical Centre, Rostock, Germany.
  • Fiedler S; European Molecular Biology Laboratory (EMBL), Hamburg Outstation/ Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany.
  • Frank M; Medical Biology and Electron Microscopy Centre, Rostock University Medical Center, Rostock, Germany; Department of Life, Light and Matter, University of Rostock, Rostock, Germany.
  • Köhling R; Oscar Langendorff Institute of Physiology, Rostock University Medical Centre, Rostock, Germany; Centre for Transdisciplinary Neurosciences Rostock, University of Rostock, Rostock, Germany.
  • Hildebrandt G; Department of Radiooncology, Rostock University Medical Centre, Rostock, Germany.
  • Hausermann D; Australian Synchrotron-Australian Nuclear Science and Technology Organisation (ANSTO), Kulin Nation, Melbourne, Australia.
  • Lerch M; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia; Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia.
  • Schültke E; Department of Radiooncology, Rostock University Medical Centre, Rostock, Germany.
Int J Radiat Oncol Biol Phys ; 114(1): 143-152, 2022 09 01.
Article em En | MEDLINE | ID: mdl-35533907
PURPOSE: Microbeam radiation therapy (MRT) has shown several advantages compared with conventional broad-beam radiation therapy in small animal models, including a better preservation of normal tissue function and improved drug delivery based on a rapidly increased vascular permeability in the target region. Normal tissue tolerance is the limiting factor in clinical radiation therapy. Knowledge of the normal tissue tolerance of organs at risk is therefore a prerequisite in evaluating any new radiation therapy approach. With an irradiation target in the thoracic cavity, the heart would be the most important organ at risk. METHODS AND MATERIALS: We used the ex vivo beating rodent heart in the Langendorff perfusion system at the synchrotron to administer microbeam irradiation (MBI) with a peak dose of 40 or 400 Gy. By continuously recording the electrocardiogram, the left ventricular pressure, and the aortic pressure before, during and after MBI, we were able to assess acute and subacute effects of MBI on electrophysiological and mechanical cardiac function. In addition, we analyzed histologic and ultrastructural sequelae caused by MBI. RESULTS: There were no significant changes in heart rate, heart rate variability, systolic increase of left ventricular pressure or aortic pressure. Moreover, the changes of heart rate, left ventricular pressure and aortic pressure by adding 10-5 mol/L norepinephrine to the perfusate, were also not significant between MBI and sham experiments. However, the rate-pressure product as a surrogate marker for maximum workload after MBI was significantly lower compared with sham-irradiated controls. On the structural level, no severe membranous, sarcomeric, mitochondrial or nuclear changes caused by MBI were detected by desmin immunohistochemistry and electron microscopy. CONCLUSIONS: With respect to acute and subacute toxicity, an MBI peak dose up to 400 Gy did not result in severe changes in cardiac electrophysiology or mechanics.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article